EC
EcoR1 Capital’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-27,208
| Closed | -$2.81M | – | 68 |
|
|
2022
Q3 | $2.81M | Buy |
+27,208
| New | +$2.81M | 0.08% | 57 |
|
|
2019
Q2 | – | Sell |
-360,819
| Closed | -$42.5M | – | 41 |
|
|
2019
Q1 | $42.5M | Sell |
360,819
-318,927
| -47% | -$37.5M | 3.91% | 9 |
|
|
2018
Q4 | $42.6M | Sell |
679,746
-407,511
| -37% | -$25.5M | 4.26% | 7 |
|
|
2018
Q3 | $77M | Sell |
1,087,257
-376,810
| -26% | -$26.7M | 6.94% | 4 |
|
|
2018
Q2 | $97.4M | Sell |
1,464,067
-358,508
| -20% | -$23.8M | 9.27% | 4 |
|
|
2018
Q1 | $119M | Sell |
1,822,575
-285,025
| -14% | -$18.6M | 11.96% | 2 |
|
|
2017
Q4 | $84.4M | Hold |
2,107,600
| – | – | 9.51% | 4 |
|
|
2017
Q3 | $76.4M | Buy |
2,107,600
+625,000
| +42% | +$22.7M | 10.18% | 4 |
|
|
2017
Q2 | $41.2M | Buy |
1,482,600
+456,900
| +45% | +$12.7M | 7.31% | 5 |
|
|
2017
Q1 | $28.7M | Buy |
1,025,700
+50,000
| +5% | +$1.4M | 7.26% | 4 |
|
|
2016
Q4 | $19.7M | Buy |
975,700
+756,500
| +345% | +$15.3M | 6.29% | 5 |
|
|
2016
Q3 | $4.41M | Buy |
+219,200
| New | +$4.41M | 1.35% | 16 |
|